Sarah Taslima is a Warrensburg, New York based female podiatrist who is specialized in Podiatry. Active license number of Sarah Taslima for Podiatry is 007387 in New York. Sarah Taslima is qualified with a Doctor of Podiatric Medicine (D.P.M.) degree, licensed by the state, and practicing within the scope of that license. She diagnose and treat foot diseases and deformities. She can perform medical, surgical and other operative procedures, prescribe corrective devices and prescribe and administer drugs and physical therapy.
Complete Profile:
Sarah Taslima speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Podiatrist
Credentials:
DPM
Gender:
Female
Practice Address:
3767 Main St, Warrensburg, New York, 12885-1890
Phone:
518-623-2844
Fax:
518-623-3416
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1578140596
NPI Enumeration Date:
25 Mar, 2021
NPI Last Update On:
28 Oct, 2024
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Sarah Taslima are as mentioned below.
License Number
Specialization
State
Status
007387
Podiatry
New York
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
9 Carey Rd, Queensbury, New York
Zip:
12804-7880
Phone Number:
518-761-0300
Fax Number:
518-824-2388
Patients can reach Sarah Taslima at 3767 Main St, Warrensburg, New York or can call to book an appointment on 518-623-2844. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.